{"id":1673,"date":"2020-10-20T10:05:58","date_gmt":"2020-10-20T17:05:58","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=1673"},"modified":"2020-10-21T10:07:17","modified_gmt":"2020-10-21T17:07:17","slug":"prevalence-and-clinical-outcomes-of-covid-19-in-patients-with-autoimmune-diseases-a-systematic-review-and-meta-analysis","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/20\/prevalence-and-clinical-outcomes-of-covid-19-in-patients-with-autoimmune-diseases-a-systematic-review-and-meta-analysis\/","title":{"rendered":"Prevalence and Clinical Outcomes of COVID-19 in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis"},"content":{"rendered":"<ul>\n<li>A meta-analysis of 7 case-control studies show 2.2-fold higher risk of COVID-19 infection among those with autoimmune diseases. Among the 2,766 patients in studies reporting clinical outcomes, use of glucocorticoids and conventional synthetic disease-modifying antirheumatic drugs were associated with increased risk of hospitalization and mortality.<\/li>\n<\/ul>\n<p>Akiyama et al. (Oct 13, 2020). Prevalence and Clinical Outcomes of COVID-19 in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Annals of the Rheumatic Diseases. <a href=\"https:\/\/doi.org\/10.1136\/annrheumdis-2020-218946\">https:\/\/doi.org\/10.1136\/annrheumdis-2020-218946<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A meta-analysis of 7 case-control studies show 2.2-fold higher risk of COVID-19 infection among those with autoimmune diseases. Among the 2,766 patients in studies reporting clinical outcomes, use of glucocorticoids and conventional synthetic disease-modifying antirheumatic drugs were associated with increased risk of hospitalization and mortality. Akiyama et al. (Oct 13, 2020). Prevalence and Clinical Outcomes&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/20\/prevalence-and-clinical-outcomes-of-covid-19-in-patients-with-autoimmune-diseases-a-systematic-review-and-meta-analysis\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[46],"topic":[20],"class_list":["post-1673","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-risk-factors","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=1673"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1673\/revisions"}],"predecessor-version":[{"id":1674,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1673\/revisions\/1674"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=1673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=1673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=1673"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=1673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}